12410sek
1,5 %
Date:2026-06-09Time:18:00:00Latest report:Q1-2026List:Mid CapTicker:BIOG B
Market Cap:12 554 msekEnterprise Value:11 682 msekNet Sales:1 544 msekEarnings:332,0 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:124,10
MA50:123,32
MA200:110,07
Price/MA200:12,7 %
RSI (14):48,9
Price/MA50:0,6 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.